Login Register Cart 0
Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

The Use of Daflon Tablets in Treating Hemorrhoids and Alleviating Symptoms

Author(s): Leila Hajimaghsoudi, Mojtaba Ahmadinejad, Mohsen Karimian, Mohammad Hadi Bahri, Ali Karbalaeikhani and Izadmehr Ahmadinejad*

Volume 19, Issue 5, 2024

Published on: 10 October, 2023

Page: [613 - 619] Pages: 7

DOI: 10.2174/0115748855260887230925095817

Price: $65

Abstract

Background: Varicose-like bulging veins that occur in the anus and lower rectum are known as hemorrhoids. Depending on their degree of prolapse, they can cause symptoms such as bleeding, discomfort, mucous discharge, perianal irritation, and burning. The aim of the study was to investigate the impact of Daflon pills on the treatment of hemorrhoids and their associated symptoms, as well as the duration of hospitalization and the likelihood of recurrence.

Methods: A randomized clinical trial was used in this investigation. Patients who had been referred to the surgical clinic of the Madani Hospital in 2021 with hemorrhoid complaints were participants in a random selection process. Participants were separated into control groups (getting non-invasive regular treatments) and the intervention group after being informed and given ethical approval (Receiving Daflon 500 mg twice daily for 4 weeks). Patients' symptoms, potential sequelae, and illness recurrence were assessed in both chosen groups at each visit, and data was gathered until the desired sample size was reached.

Results: This study was performed on 200 patients who received Daflon 500 mg (intervention, N = 100) or placebo (control, N = 100). The number of visits required to achieve therapeutic goals did not differ statistically significantly between the intervention and control groups (P > 0.05). The mean recovery time was 56.5 ± 12.53 days for the intervention group and 61.04 ± 13.63 days for the control group, which is considered statistically significant (P < 0.05). A total of 56 patients (28.0%) relapsed and 144 patients (72.0%) recovered. This rate in the intervention group included 78 (78.0%) recovery and 22 (22.0%) relapsed and in the control group 66 (66.0%) recovered and 34 (34.0%) relapsed, clinically it suggests that treatment Daflon can prevent relapse of the disease, although the statistical results of this study do not support this hypothesis (P = 0.059).

Conclusion: The study's findings demonstrated that Daflon therapy is a superior and more effective treatment option for all grades of hemorrhoids. Moreover, the medication's side effects are manageable, making it a well-tolerated choice.

« Previous
[1]
Aggrawal K, Satija N, Dasgupta G, Dasgupta P, Nain P, Sahu AR. Efficacy of a standardized herbal preparation (Roidosanal(®)) in the treatment of hemorrhoids: A randomized, controlled, open-label multicentre study. J Ayurveda Integr Med 2014; 5(2): 117-24.
[PMID: 24948863]
[2]
Rahmani P, Heidari G, Farahmand F, Moradzadeh A. Relationship of citrulline and tissue transglutaminase antibody with duodenal histopathology among children with celiac disease. Ann Med Surg 2022; 76: 103489.
[http://dx.doi.org/10.1016/j.amsu.2022.103489] [PMID: 35340324]
[3]
Thomson WH. The nature of haemorrhoids. Br J Surg 1975; 62(7): 542-52. Available from: https://www.scirp.org/(S(351jmbntvnsjt1aadkposzje))/reference/referencespapers.aspx?referenceid=1921379
[4]
Lacerda-Filho A, Silva RG. Stapled hemorrhoidectomy: Present status. Arq Gastroenterol 2005; 42(3): 191-4. Available from: https://www.scielo.br/j/ag/a/X4Cg3nXXXT9m9yK7m8ZQ6Nd/?lang=en
[5]
Nisar PJ, Scholefield JH. Managing haemorrhoids. BMJ 2003; 327(7419): 847-51.
[PMID: 14551102]
[6]
Lohsiriwat V. Anatomy, physiology, and pathophysiology of hemorrhoids. In: Ratto C, Parello A, Litta F, Eds. Hemorrhoids. Cham: Springer International Publishing 2018; pp. 9-17.
[http://dx.doi.org/10.1007/978-3-319-53357-5_2]
[7]
Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol 2012; 18(17): 2009-17.
[http://dx.doi.org/10.3748/wjg.v18.i17.2009] [PMID: 22563187]
[8]
Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids. Cochrane Database Syst Rev 2005; 2005(1): CD005034.
[PMID: 8860341]
[9]
American Gastroenterological Association Technical Review on the Diagnosis and Treatment of Hemorrhoids — Experts@ Minnesota. Available from: https://experts.umn.edu/en/publications/american-gastroenterological-association-technical-review-on-the-
[10]
Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist’s view. World J Gastroenterol 2015; 21(31): 9245-52.
[http://dx.doi.org/10.3748/wjg.v21.i31.9245] [PMID: 26309351]
[11]
Guidelines for the treatment of hemorrhoids (short report). - Vein academy. Available from: https://vein-academy.servier.com/library/guidelines-for-the-treatment-of-hemorrhoids-short-report/
[12]
Hemorrhoids: Diagnosis and treatment options. Available from: https://www.researchgate.net/publication/323165954_Hemorrhoids_Diagnosis_and_Treatment_Options
[13]
Di Pierro F, Spinelli G, Monsù G, et al. Clinical effectiveness of a highly standardized and bioavailable mixture of flavonoids and triterpenes in the management of acute hemorroidal crisis. Acta Biomed 2011; 82(1): 35-40.
[PMID: 22069954]
[14]
Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003; 63(1): 71-100.
[http://dx.doi.org/10.2165/00003495-200363010-00005] [PMID: 12487623]
[15]
Phlebotonics for haemorrhoids. Available from: https://www. cochrane.org/CD004322/COLOCA_phlebotonics-for-haemorrhoids (Accessed on: Apr 5, 2023).
[16]
Pecorini G, Ferraro E, Puppi D. Polymeric systems for the controlled release of flavonoids. Pharmaceutics 2023; 15(2): 628.
[http://dx.doi.org/10.3390/pharmaceutics15020628] [PMID: 36839955]
[17]
Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2016; 2016(4): CD003229.
[PMID: 7173720]
[18]
Khan MA, Chowdri NA, Parray FQ, et al. “PNR-Bleed” classification and Hemorrhoid Severity Score—a novel attempt at classifying the hemorrhoids. J Coloproctol 2020; 40(4): 398-403.
[http://dx.doi.org/10.1016/j.jcol.2020.05.012]
[19]
Heidari G, Motamed F, Heirati B, Rahmani P. Diagnostic performance of noninvasive methods for liver biopsy by fibroscan in pediatric. Journal of Child Science 2021; 11(01): e55-9. Available from: https://www.thieme-connect.com/products/ejournals/ abstract/10.1055/s-0041-1725079
[20]
MG-29-za. Available from: https://ljkzedo.ba/wordpress/wp-content/uploads/2018/07/MG-29-za-web.pdf#page=13
[21]
Dewan B, Prabhu S. Evaluation of hilo® versus daflon® in patients suffering from hemorrhoids: A randomized, controlled, open-labelled, multicentric study. J Adv Med Med Res 2019; 1-12.
[http://dx.doi.org/10.9734/jammr/2019/v30i630206]
[22]
Ramelet AA. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology 2001; 52 (Suppl. 1): S49-56.
[http://dx.doi.org/10.1177/0003319701052001S07] [PMID: 11510597]
[23]
Diana G, Catanzaro M, Ferrara A, Ferrari P. Activity of purified diosmin in the treatment of hemorrhoids. Clin Ter 2000; 151(5): 341-4.
[PMID: 11141716]
[24]
Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial. Tech Coloproctol 2015; 19(6): 339-45.
[25]
Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. 1994. Available from: https://journals.sagepub.com/doi/10.1177/000331979404500614 (Accessed on: Apr 5, 2023).
[26]
Ho YH, Tan M, Seow-Choen F. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids. Dis Colon Rectum 2000; 43(1): 66-9.
[http://dx.doi.org/10.1007/BF02237246] [PMID: 10813126]
[27]
The efficacy of adding Daflon to the conventional treatment on the improvement of symptoms and health related quality of life in patients with acute hemorrhoids medicine. Available from: https://www.semanticscholar.org/paper/The-Efficacy-of-Adding-Daflon-to-the-Conventional-A-Mokhtare-Pakravan/ca0db2d1d73a309a8a44a2c447945f15e6abcbb9 (Accessed on: Apr 5, 2023).
[28]
Meshikhes A-W. Efficacy of Daflon in the treatment of hemorrhoids. Saudi Med J 2002; 23(12): 1496-8.
[PMID: 12518200]
[29]
Meshikhes A-W. Daflon for haemorrhoids: A prospective, multicentre observational study. Surg J R Coll Surg Edinb Irel 2004; 2(6): 335-338. 361.
[http://dx.doi.org/10.1016/S1479-666X(04)80032-5]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy